B

바이오플러스

099430KOSDAQ

61.3 / 100

Reference Date: 2026-09-08

Financial Score26.0 / 40
News Sentiment21.3 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 7.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

BioPlus is a company specializing in the development and sale of medical devices, bio-pharmaceuticals, and bio-cosmetics, leveraging technologies such as MDM and temperature-sensitive materials to enhance product performance. To expand globally, the company has established a foreign subsidiary in Hainan, China, and operates a large-scale factory in Chungcheongbuk, South Korea, focusing on improving profitability.

Number of Employees

187people

Average Salary

60.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
13.40Industry Average 15.005.0Point

In line with industry avg

PBR
1.07Industry Average 1.204.0Point

In line with industry avg

ROE
11.67Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
6.54Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲19.5% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼26.1% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 15.2% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 3,390Won52-week high 7,20052-week low 3,300
1-month return2.0Point

1m -7.00% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14